E Cakal1, M Ozkaya, Y Engin-Ustun, Y Ustun. 1. Department of Endocrinology, Yuksek Ihtisas Education and Research Hospital, Ankara, Turkey. ermancakal@hotmail.com
Abstract
BACKGROUND: Our aim was to investigate levels of lipocalin-2 and its relationship with metabolic factors in women with polycystic ovary syndrome (PCOS). MATERIALS/SUBJECTS AND METHODS: In this cross-sectional study, two groups of women were studied: group 1 consisted of women with PCOS (no.=30), and group 2 consisted of control women with normal ovulatory function (no.=30). The circulating levels of free testosterone (T), DHEAS, glucose, insulin, triglycerides (TG), HDL, LDL and lipocalin were measured. Insulin resistance was assessed using the homeostasis model assessment (HOMA-IR). In order to determine a lipocalin value indicating insulin resistance, receiver operating characteristic (ROC) curves were established. RESULTS: Serum lipocalin was significantly higher in PCOS subjects (54.26 ± 15.58 vs 26.09 ± 7.47 ng/ml, p=0.0001).We found a close correlation between lipocalin and insulin, lipocalin and HOMA-IR, lipocalin and T, and lipocalin and DHEAS. A cut-off level of >39.54 ng/ml for serum lipocalin has a predictive value for insulin resistance of 81% sensitivity and 82.1% specificity. CONCLUSION: In our study, lipocalin-2 levels were found to be significantly higher in women with PCOS compared to body mass index-matched controls. Serum lipocalin-2 may prove to be a useful marker for insulin resistance in patients with PCOS.
BACKGROUND: Our aim was to investigate levels of lipocalin-2 and its relationship with metabolic factors in women with polycystic ovary syndrome (PCOS). MATERIALS/SUBJECTS AND METHODS: In this cross-sectional study, two groups of women were studied: group 1 consisted of women with PCOS (no.=30), and group 2 consisted of control women with normal ovulatory function (no.=30). The circulating levels of free testosterone (T), DHEAS, glucose, insulin, triglycerides (TG), HDL, LDL and lipocalin were measured. Insulin resistance was assessed using the homeostasis model assessment (HOMA-IR). In order to determine a lipocalin value indicating insulin resistance, receiver operating characteristic (ROC) curves were established. RESULTS: Serum lipocalin was significantly higher in PCOS subjects (54.26 ± 15.58 vs 26.09 ± 7.47 ng/ml, p=0.0001).We found a close correlation between lipocalin and insulin, lipocalin and HOMA-IR, lipocalin and T, and lipocalin and DHEAS. A cut-off level of >39.54 ng/ml for serum lipocalin has a predictive value for insulin resistance of 81% sensitivity and 82.1% specificity. CONCLUSION: In our study, lipocalin-2 levels were found to be significantly higher in women with PCOS compared to body mass index-matched controls. Serum lipocalin-2 may prove to be a useful marker for insulin resistance in patients with PCOS.
Authors: K C Lewandowski; J Komorowski; C J O'Callaghan; B K Tan; J Chen; G M Prelevic; H S Randeva Journal: J Clin Endocrinol Metab Date: 2005-12-06 Impact factor: 5.958
Authors: Susanne Hahn; Manuel Backhaus; Martina Broecker-Preuss; Susanne Tan; Tiina Dietz; Rainer Kimmig; Markus Schmidt; Klaus Mann; Onno E Janssen Journal: Eur J Endocrinol Date: 2007-08 Impact factor: 6.664
Authors: Li Weiping; Cheng Qingfeng; Ma Shikun; Liu Xiurong; Qin Hua; Bai Xiaoshu; Zhang Suhua; Li Qifu Journal: Endocrine Date: 2006-12 Impact factor: 3.925
Authors: M Ángeles Martínez-García; Samuel Moncayo; María Insenser; Francisco Álvarez-Blasco; Manuel Luque-Ramírez; Héctor F Escobar-Morreale Journal: Nutrients Date: 2019-10-24 Impact factor: 5.717